126 related articles for article (PubMed ID: 8993869)
1. Radioimmunoscintigraphy in patients with ocular melanoma.
Sergieva SB; Virtcheva-Genkova A
Clin Nucl Med; 1997 Jan; 22(1):25-9. PubMed ID: 8993869
[TBL] [Abstract][Full Text] [Related]
2. Ocular radioimmunoscintigraphy: sensitivity and practical considerations.
Bomanji J; Nimmon CC; Hungerford JL; Solanki K; Granowska M; Britton KE
J Nucl Med; 1988 Jun; 29(6):1031-7. PubMed ID: 3373313
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ocular tumors with technetium-99m-MIBI: planar pinhole technique or SPECT?
Alonso O; Núñez M; Cánepa J; Guisoli P; Mut F; Lago G; Touya E
J Nucl Med Technol; 2000 Jun; 28(2):85-7. PubMed ID: 10824618
[TBL] [Abstract][Full Text] [Related]
4. Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma.
Blend MJ; Hyun H; Patel B; Sullivan K; Salk D
J Nucl Med; 1996 Feb; 37(2):252-7. PubMed ID: 8667055
[TBL] [Abstract][Full Text] [Related]
5. Role of radioimmunoscintigraphy and SPET in the diagnosis of patients with malignant melanoma.
Sergieva S; Goranov K; Piperkova E; Tzingilev D; Trojanova P; Peitcheva E; Kulkin V
Nucl Med Commun; 1994 Mar; 15(3):168-72. PubMed ID: 8190407
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunoscintigraphy with 99mTc-225.28S-F(ab')2 in cutaneous and ocular melanomas: cases of particular clinical interest.
Salzillo F; Mele M; Lombardo T; Delle Noci N; Minervini C; D'Addabbo A
J Nucl Biol Med (1991); 1993 Dec; 37(4):191-7. PubMed ID: 8172959
[TBL] [Abstract][Full Text] [Related]
7. Scintigraphic visualization of ocular melanoma with Tc-99m glutathione.
Tutuş A; Erkiliç K; Ercan MT; Kontaş O; Aydin M; Doğan H
Ann Nucl Med; 1997 May; 11(2):143-6. PubMed ID: 9212895
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoscintigraphy with Tc-99m labeled monoclonal antibody 170H.82 in suspected primary, recurrent, or metastatic breast cancer.
Lind P; Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Omann J; Dinges HP; Boniface G
Clin Nucl Med; 1997 Jan; 22(1):30-4. PubMed ID: 8993870
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoscintigraphy and biodistribution of technetium-99m-labeled monoclonal antibody U36 in patients with head and neck cancer.
de Bree R; Roos JC; Quak JJ; den Hollander W; Snow GB; van Dongen GA
Clin Cancer Res; 1995 Jun; 1(6):591-8. PubMed ID: 9816020
[TBL] [Abstract][Full Text] [Related]
10. [Immunoscintigraphy results in the comparison of ocular with cutaneous melanoma].
Löffler KU; Bräutigam P; Simon J; Althauser SR; Moser E; Witschel H
Ophthalmologe; 1994 Aug; 91(4):529-32. PubMed ID: 7950129
[TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy with anti-225.28S for ocular melanoma--a comparison with histology and immunohistochemistry.
Bräutigam P; Loeffler KU; Krause T; Högerle S; Simon J; Moser E
Nuklearmedizin; 1997 Mar; 36(2):42-6. PubMed ID: 9090646
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of ocular melanoma immunoscintigraphy.
Janković Z; Pucar D; Jauković L; Ajdinović B
J BUON; 2006; 11(3):347-50. PubMed ID: 17309161
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography.
Wahl RL; Swanson NA; Johnson JW; Natale R; Petry NA; Mallette S; Kasina S; Reno J; Sullivan K; Abrams P
Am J Physiol Imaging; 1992; 7(2):48-58. PubMed ID: 1419120
[TBL] [Abstract][Full Text] [Related]
14. Preoperative diagnosis of ovarian carcinoma with a novel monoclonal antibody.
Lieberman G; Buscombe JR; Hilson AJ; Reid WM; Thakrar D; Maclean AB
Am J Obstet Gynecol; 2000 Sep; 183(3):534-40. PubMed ID: 10992170
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoscintigraphy of colorectal carcinoma using technetium-99m-labeled, totally human monoclonal antibody 88BV59H21-2.
Gulec SA; Serafini AN; Moffat FL; Vargas-Cuba RD; Sfakianakis GN; Franceschi D; Crichton VZ; Subramanian R; Klein JL; De Jager RL
Cancer Res; 1995 Dec; 55(23 Suppl):5774s-5776s. PubMed ID: 7493345
[TBL] [Abstract][Full Text] [Related]
16. Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients.
Blend MJ; Ronan SG; Salk DJ; Gupta TK
J Clin Oncol; 1992 Aug; 10(8):1330-7. PubMed ID: 1634923
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunodetection and radioimmunotherapy of malignant melanoma. A review.
Liewendahl K; Pyrhönen S
Acta Oncol; 1993; 32(7-8):717-21. PubMed ID: 8305217
[TBL] [Abstract][Full Text] [Related]
18. Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma.
Magnani P; Paganelli G; Modorati G; Zito F; Songini C; Sudati F; Koch P; Maecke HR; Brancato R; Siccardi AG; Fazio F
J Nucl Med; 1996 Jun; 37(6):967-71. PubMed ID: 8683323
[TBL] [Abstract][Full Text] [Related]
19. Clinical role of 123I-IMP SPECT for the differential diagnosis of ocular malignant melanoma: a time-course analysis.
Abe K; Sasaki M; Koga H; Kaneko K; Sawamoto H; Yoshikawa H; Honda H
Nucl Med Commun; 2007 Jul; 28(7):567-73. PubMed ID: 17538399
[TBL] [Abstract][Full Text] [Related]
20. [Values and limitations of radioimmunoscintigraphy with MoAb 225-28S in the diagnosis of posterior uveal melanoma].
Cavazza S; Tassoni A; Abbati A
J Fr Ophtalmol; 1992; 15(6-7):395-9. PubMed ID: 1294595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
